The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKa2
Journal article
Lee, Jung Ok, Byun, Won Seok, Kang, Min Ju, Han, Jeong Ah, Moon, Jiyoung, Shin, Min-Jeong, Lee, Ho Jun, Chung, Ji Hyung, Lee, Jin-Seok, Son, Chang-Gue, Song, Kwon-Ho, Kim, Tae Woo, Lee, Eun-Soo, Kim, Hong Min, Chung, Choon Hee, Ngoei, Kevin R. W., Ling, Naomi X. Y., Oakhill, Jonathan S., Galic, Sandra, ... Kim, Hyeon Soo. (2020). The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKa2. The FEBS Journal. 287(10), pp. 2087-2104. https://doi.org/10.1111/FEBS.15301
Authors | Lee, Jung Ok, Byun, Won Seok, Kang, Min Ju, Han, Jeong Ah, Moon, Jiyoung, Shin, Min-Jeong, Lee, Ho Jun, Chung, Ji Hyung, Lee, Jin-Seok, Son, Chang-Gue, Song, Kwon-Ho, Kim, Tae Woo, Lee, Eun-Soo, Kim, Hong Min, Chung, Choon Hee, Ngoei, Kevin R. W., Ling, Naomi X. Y., Oakhill, Jonathan S., Galic, Sandra, Murray-Segal, Lisa, Kemp, Bruce E., Kim, Kyoung Min, Lim, Soo and Kim, Hyeon Soo |
---|---|
Abstract | Meteorin‐like (metrnl) is a recently identified adipomyokine that beneficially affects glucose metabolism; however, its underlying mechanism of action is not completely understood. We here show that the level of metrnl increases in vitro under electrical pulse stimulation and in vivo in exercised mice, suggesting that metrnl is secreted during muscle contractions. In addition, metrnl increases glucose uptake via the calcium‐dependent AMPKα2 pathway in skeletal muscle cells and increases the phosphorylation of HDAC5, a transcriptional repressor of GLUT4, in an AMPKα2‐dependent manner. Phosphorylated HDAC5 interacts with 14‐3‐3 proteins and sequesters them in the cytoplasm, resulting in the activation of GLUT4 transcription. An intraperitoneal injection of recombinant metrnl improved glucose tolerance in mice with high‐fat‐diet‐induced obesity or type 2 diabetes, but not in AMPK β1β2 muscle‐specific null mice. Metrnl improves glucose metabolism via AMPKα2 and is a promising therapeutic candidate for glucose‐related diseases such as type 2 diabetes. |
Keywords | adipomyokine; AMPK; glucose uptake; Metrnl; type 2 diabetes |
Year | 2020 |
Journal | The FEBS Journal |
Journal citation | 287 (10), pp. 2087-2104 |
Publisher | Wiley-Blackwell Publishing Ltd. |
ISSN | 1742-464X |
Digital Object Identifier (DOI) | https://doi.org/10.1111/FEBS.15301 |
Scopus EID | 2-s2.0-85083494330 |
Open access | Published as ‘gold’ (paid) open access |
Research or scholarly | Research |
Page range | 2087-2104 |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
Online | 19 Apr 2020 |
Publication process dates | |
Accepted | 17 Mar 2020 |
Deposited | 10 May 2021 |
https://acuresearchbank.acu.edu.au/item/8vzy5/the-myokine-meteorin-like-metrnl-improves-glucose-tolerance-in-both-skeletal-muscle-cells-and-mice-by-targeting-ampka2
Download files
Publisher's version
OA_Lee_2020_The_myokine_meteorin_like_metrnl_improves.pdf | |
License: CC BY 4.0 | |
File access level: Open |
147
total views60
total downloads0
views this month0
downloads this month